KRAS and melanoma: As expected, KRAS mutation dependence was observed in colon, pancreatic and lung cancer cell lines, NRAS mutation dependence in melanoma lines, and BRAF mutation dependence in colon, thyroid and melanoma lines (McDonald et al, 2017).